Erratum: Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure (Cardiovascular Research (2020) 87 (524-534) DOI: 10.1093/cvr/cvq068);Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure

Cardiovascular Research

Volumn 87, Issue 3, 2010, Pages 524-534

  Das, Biswajit ^a   Young, David ^a   Vasanji, Amit ^a   Gupta, Sudhiranjan ^a,b   Sarkar, Sagartirtha ^a,c   Sen, Subha ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF CALCUTTA   (India)

Author keywords

Cardiac hypertrophy; Heart failure; Myotrophin; P53

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; RECOMBINANT SOMATOMEDIN C; SIGNAL PEPTIDE; TP53 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENHANCER REGION; GENE EXPRESSION PROFILING; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CARDIOMEGALY; CELL CULTURE; DEFICIENCY; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; RAT; TIME; TRANSGENIC MOUSE; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HEART FAILURE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROKE VOLUME; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; VENTRICULAR FUNCTION, LEFT;

EID: 77954768186     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvab002     Document Type: Erratum

References (45)

1. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation 2000;102:IV14-IV23.
2. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007;446: 444-448.
3. Birks EJ, Latif N, Enesa K, Folkvang T, Luong lASarathchandraP et al. Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res 2008;79:472-480.
4. Tsukamoto O, Minamino T, Okada K, Shintani Y, Takashima S, Kato H et al. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 2006;340: 1125-1133.
5. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F et al. Ablation of tel-omerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J 2003;22:131-139.
6. Efeyan A, p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 2007;6:1006-1010.
7. Venkatakrishnan CD, Dunsmore K, Wong H, Roy S, Sen CK, Wani A et al. HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest. Am J Physiol Heart Circ Physiol 2008;294:H1736-H1744.
8. Oie E, Clausen OP, Yndestad A, Grogaard HK, Attramadal H. Endothelin receptor antagonism attenuates cardiomyocyte apoptosis after induction of ischemia in rats. Scand Cardiovasc J 2002;36:108-116.
9. Ikeda S, Hamada M, Hiwada K. Cardiomyocyte apoptosis with enhanced expression of P53 and Bax in right ventricle after pulmonary arterial banding. Life Sci 1999;65: 925-933.
10. Sen S, Kundu G, Mekhail N, Castel J, Misono K, Healy B. Myotrophin: purification of a novel peptide from spontaneously hypertensive rat heart that influences myocardial growth. J Biol Chem 1990;265:16635-16643.
11. Sarkar S, Leaman DW, Gupta S, Sil P, Young D, Morerhead A et al. Cardiac expression of myotrophin triggers myocardial hypertrophy and heart failure in trans-genic mice: Changes in gene expression profiles during initiation of hypertrophy and during heart failure measured by DNA microarray analysis. J Biol Chem 2004;279: 20422-20434.
12. Das B, Gupta S, Vasanji A, Xu Z, Misra S, Sen S. Nuclear co-translocation of myotro-phin and p65 stimulates myocyte growth: regulation by myotrophin hairpin loops. J Biol Chem 2008;283:27947-27956.
13. Sarkar S, Chawla-Sarkar M, Young D, Nishiyama K, Rayborn ME, Hollyfield JG et al. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure. J Biol Chem 2004;279:52630-52642. (Pubitemid 39656639)
14. Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol Cell Biochem 2005;273: 25-32.
15. Tachibana H, Naga Prasad SV, Lefkowitz RJ, Koch WJ, Rockman HA. Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure. Circulation 2005;111:591-597.
16. Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR et al. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J 1997;16: 1391-1400.
17. Gupta S, Sen S. Role of the NF-kappaB signaling cascade and NF-kappaB-targeted genes in failing human hearts. J Mol Med 2005;83:993-1004.
18. Ju J, Schmitz JC, Song B, Kudo K, Chu E. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells. Clin Cancer Res 2007;13:4245-4251.
19. Rouet-Benzineb P, Gontero B, Dreyfus P, Lafuma C. Angiotensin II induces nuclear factor-kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J Mol Cell Cardiol 2000;32:1767-1778.
20. Onohara N, Nishida M, Inoue R, Kobayashi H, Sumimoto H, Sato Y et al. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J 2006;25: 5305-5316.
21. Peng Y, Popovic ZB, Sopko N, Drinko J, Zhang Z, Thomas JD et al. Speckle tracking echocardiography in the assessment of mouse models of cardiac dysfunction. Am J Physiol Heart Circ Physiol 2009;297:H811-H820.
22. Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA et al. A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2009;284:27487-27499.
23. Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purified components. Methods Enzymol 1983;101:582-598.
24. Gupta S, Purcell NH, Lin A, Sen S. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 2002;159:1019-1028.
25. Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D et al. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J 1998;17:4657-4667.
26. Sil P, Misono K, Sen S. Myotrophin in human cardiomyopathic heart. Circ Res 1993;73: 98-108.
27. Sil P, Gupta S, Young D, Sen S. Regulation of myotrophin gene by pressure overload and stretch. Mol Cell Biochem 2004;262:79-89.
28. Sil P, Mukherjee DP, Sen S. Quantification of myotrophin from spontaneously hypertensive and normal rat hearts. Circ Res 1995;76:1020-1027.
29. O'Brien RJ, Loke I, Davies JE, Squire IB, Ng LL. Myotrophin in human heart failure. J Am Coll Cardiol 2003;42:719-725.
30. Song H, Conte JV Jr, Foster AH, McLaughlin JS, Wei C. Increased p53 protein expression in human failing myocardium. J Heart Lung Transplant 1999;18:744-749.
31. Li P, Li J, Feng X, Li Z, Hou R, Han C et al. Gene expression profile of cardiomyocytes in hypertrophic heart induced by continuous norepinephrine infusion in the rats. Cell Mol Life Sci 2003;60:2200-2209.
32. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K et al. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardio-vasc Res 2006;70:457-465.
33. Depke M, Steil L, Domanska G, Volker U, Schutt C, Kiank C. Altered hepatic mRNA expression of immune response and apoptosis-associated genes after acute and chronic psychological stress in mice. Mol Immunol 2009;46:3018-3028.
34. Cao X, Plasencia C, Kanzaki A, Yang A, Burke TR Jr, Neamati N. Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis. Curr Cancer Drug Targets 2009;9:189-201.
35. McCarthy N, Mercer J, Bennett M. Apoptotic proteins. p53 and c-myc related pathways. Cardiol Clin 2001;19:75-89. viii.
36. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141.
37. Moorjani N, Catarino P, Trabzuni D, Saleh S, Moorji A, Dzimiri N et al. Upregulation of Bcl-2 proteins during the transition to pressure overload-induced heart failure. Int J Cardiol 2007;116:27-33.
38. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL et al. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 2008; 375:637-649.
39. Dreyfus DH, Nagasawa M, Gelfand EW, Ghoda LY. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors. BMC Immunol 2005;6:12.
40. Webster GA, Perkins ND. Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 1999;19:3485-3495.
41. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274:782-784.
42. Bertrand F, Atfi A, Cadoret A, L'Allemain G, Robin H, Lascols O et al. A role for nuclear factor kappaB in the antiapoptotic function of insulin. J Biol Chem 1998;273: 2931-2938.
43. Klefstrom J, Arighi E, Littlewood T, Jaattela M, Saksela E, Evan GI et al. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. EMBO J 1997;16:7382-7392.
44. Hall PA, Meek D, Lane DP. p53\integrating the complexity. J Pathol 1996;180:1-5.
45. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.